CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales	$ 1,994,011	$ 4,186,516	$ 4,511,983	$ 6,651,685
Cost of goods sold	513,857	649,220	1,064,599	1,121,560
Gross profit	1,480,154	3,537,296	3,447,384	5,530,125
Operating expenses:
Selling, general and administrative	2,249,592	3,216,604	4,380,231	7,114,342
Gain on settlement with Vivus				(3,389,941)
Research and development expense	866,575	421,242	1,185,668	826,602
Depreciation and amortization expense	826,795	1,560,870	1,653,590	3,121,740
Total operating expenses	3,942,962	5,198,716	7,219,489	7,672,743
Loss from operations	(2,462,808)	(1,661,420)	(3,772,105)	(2,142,618)
Change in fair value of derivative liability				460,000
Interest income	(52,924)		(119,241)
Interest expense, promissory note	(136,799)	(150,372)	(278,966)	(303,398)
Net Income (loss)	$ (2,546,683)	$ (1,811,792)	$ (3,931,830)	$ (1,986,016)
Net Income (loss) per common share
Basic (in dollars per share)	$ (1.20)	$ (0.88)	$ (1.87)	$ (0.96)
Diluted (in dollars per share)	$ (1.20)	$ (0.88)	$ (1.87)	$ (0.96)
Weighted average common shares outstanding
Basic	2,117,581	2,068,472	2,103,220	2,068,472
Diluted	2,117,581	2,068,472	2,103,220	2,068,472